Skip to main content

Access & Affordability

Image of a pediatric patient playing T-ball with text stating "Support for your eligible patients throughout the treatment journey. Help your patients start and stay on therapy"

Overview

PROMACTA offers excellent coverage for patients
~99% icon

of patients have PROMACTA included on their health plan’s formulary1,*

*Includes all categories except Not Covered. The small portion of claims with Unknown status were proportionately redistributed across all categories.1
 

Novartis Patient Support™

To learn more, call 1-800-282-7630.

Universal Co-pay Program

Patients may be eligible for immediate co-pay savings on their next prescription of PROMACTA2

  • Eligible patients with private insurance may pay $0 per month for PROMACTA

  • Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product

  • Encourage your patients to find out if they are eligible to enroll in the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756.

Limitations apply. This offer is only available to patients with private insurance. The program is not available for patients who are enrolled in Medicare, Medicaid, or any other federal or state health care program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-877-577-7756.

References:
  1. Data on file. MMIT, ITP market basket (commercial + Medicare). Novartis Pharmaceuticals Corp; March 2023.
  2. Data on file. IQVIA, anonymized patient-level data for FY2022. Novartis Pharmaceuticals Corp; March 2023.